Benjamin L. Oakes owns 2.68% of Scribe Therapeutics
506,602 shares as of the July 23, 2026 filing, worth $7.9M at the latest close.
SCTX · $295M market cap · Founder-ledGet an email when Benjamin L. Oakes’s stake moves.
Free.
The stake
2.68%
worth $7.9M at the latest close
Stake rank
#1,861
by dollar value of the stake
Last sale
None
no sales since 2016
Last buy
None
no purchases since 2016
Benjamin L. Oakes owns 2.68% of Scribe Therapeutics, Inc.: 506,602 of 18,931,680 shares, worth about $7.9M at the 2026-10-26 close.
How the stake is held
as of the Jul 23, 2026 filing
SHARES
OF THE STAKE
COMMON STOCK · stated Jul 23, 2026 · Form 4 ↗
HELD DIRECTLY
506,602
100.0%
THE STAKE
506,602
2.68%